Occupation or Discipline – Page 10

Ipsen and Biomunex Partner on First-in-Class MAIT Cell Engager for Solid Tumors in $610M Deal

9 months ago talkbio0Tagged Biomunex, BiXAb, BMX-502, cell engager, cytarabine/methotrexate protocol, GPC3 tumor antigen, immuno-oncology, Ipsen, Solid Neoplasm, T-Lymphocyte, Technology

Ipsen, Biomunex, MAIT cell engager, T cell engager, solid tumors, immuno-oncology, BMX-502, BiXAb technology, GPC3 tumor antigen.

Novartis Announces 139 Job Cuts in New Jersey Amid Commercial Refocus

10 months ago talkbio0Tagged commercial refocus, New Jersey, Novartis, restructuring

Novartis, job cuts, New Jersey, commercial refocus, restructuring

Embecta Discontinues Insulin Patch Pump Program Amid Restructuring Efforts

10 months ago talkbio0Tagged Diabetes, Discontinuation (procedure), Embecta, insulin patch, pump (device), restructuring, Technology

Embecta, insulin patch pump, discontinuation, restructuring, layoffs, diabetes technology

Sarepta Therapeutics and Arrowhead Pharmaceuticals Enter $10 Billion Collaboration for Rare Disease Treatments

10 months ago talkbio0Tagged Arrowhead, biotech, Collaboration, Drug Industry, Genetic Medicine, Infrequent, RNA Interference

Sarepta Therapeutics, Arrowhead Pharmaceuticals, RNAi, Rare Diseases, Genetic Medicine, Collaboration Agreement, Biotech, Pharmaceutical Industry

Empowering Women in Life Sciences: 2024’s Trailblazers in Biopharma R&D

10 months ago talkbio0Tagged 2024, Biological Science Disciplines, Biopharma, Fiercest, Gender, Health care facility, innovation, R&D, Women

Women in Life Sciences, Biopharma R&D, 2024’s Fiercest Women, Gender Balance, Innovation in Healthcare

Unlocking Health Equity: Leveraging Comprehensive SDOH Market Insights for Enhanced Treatment, Access, and Adherence

10 months ago talkbio0Tagged Adherence, Adherence (attribute), Data Analytics, Health care facility, Health Equity, Market, outcomes, public health medicine (field), Social Determinants of Health

Social Determinants of Health (SDOH), Health Equity, Market Insights, Treatment Access, Adherence, Healthcare Outcomes, Data Analytics, Public Health

UK Health Secretary Warns Against Misuse of GLP-1 Weight Loss Drugs for Aesthetic Purposes

10 months ago talkbio0Tagged agonists, Cautionary Warning, Esthetics (discipline), Glucagon-Like Peptide 1, health secretary, MHRA, MISUSE, UK, Weight Loss, Weight-Loss Agents

GLP-1 agonists, weight loss drugs, misuse, aesthetic weight loss, UK health secretary, MHRA warnings

Historic Settlement: Lacks Family Reaches Agreement with Thermo Fisher Scientific Over Unjust Enrichment from HeLa Cells

10 months ago talkbio0Tagged Biotechnology, Consent, HeLa Cells, Henrietta Lacks, racial injustice, Science, settlement, Thermo Fisher

Henrietta Lacks, HeLa cells, Thermo Fisher Scientific, unjust enrichment, racial injustice, medical ethics, consent, biotechnology, settlement.

Novo Nordisk and Ascendis Pharma Collaborate on Groundbreaking Once-Monthly GLP-1 Treatment for Obesity and Type 2 Diabetes

10 months ago talkbio0Tagged Ascendis, Cardiovascular system, GLP-1 receptor, Metabolic Diseases, Nordisk, Obesity, once-monthly, Pharma, Technology, TransCon

Novo Nordisk, Ascendis Pharma, GLP-1 receptor agonist, once-monthly treatment, obesity, type 2 diabetes, metabolic diseases, cardiovascular therapies, TransCon technology.

Merck’s Gardasil Sales in China Continue to Decline Amid Economic and Regulatory Challenges

10 months ago talkbio0Tagged China, Economics, Gardasil, Merck, regulatory issues, Vaccines

Merck, Gardasil, China, vaccine sales, economic challenges, regulatory issues